Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
COVID-19 Therapy Based on AI Pharmaceutical Biotech and Ethnobotanicals with Dr. Saran Saund Oncotelic Therapeutics TRANSCRIPT
Download PDFDec 24, 2020
Dr. Saran Saund, Chief Business Officer, Oncotelic Therapeutics is an immuno-oncology company dedicated to developing RNA cancer therapies for melanoma and pancreatic cancer using their nano molecular therapy platform. Using AI they recently screened several of their own molecules and ethnobotanicals for COVID-19. As a result Oncotelic has developed a compound based on an ancient ayurvedic artemisinin-based therapy using the active ingredient from the plant artemisia, also known as sweet wormwood. The tablet formulation of ARTIVeda would allow for efficient distribution to a global audience at a fraction of the cost of current therapies like Remdesivir.
#Oncotelic #COVID19 #COVIDTherapies #ARTIVeda
